Cargando…

I-14 Molecular pathomechanism of DM2/PROMM: similarities and differences between DM1 and DM2

Detalles Bibliográficos
Autor principal:	Meola, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Lectures by Invited Speakers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235851/

Ejemplares similares

DM-Ice
por: Seo, Seon-Hee
Publicado: (2011)

T2DM: Why Epigenetics?
por: Fradin, Delphine, et al.
Publicado: (2011)

I-3 Treatment of CPT2 deficiency with bezafibrate
por: Laforet, P.
Publicado: (2011)

Consequences of DM/antiDM Oscillations for Asymmetric WIMP Dark Matter
por: Cirelli, Marco, et al.
Publicado: (2011)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

I-2 Can we bypass a muscle metabolic defect?
por: Argov, Z.
Publicado: (2011)

DM at the LHC, an overview
por: Wang, Renjie
Publicado: (2019)

The ArDM experiment
por: Haranczyk, M, et al.
Publicado: (2010)

Searches for DM with ATLAS
por: Gonzalez Fernandez, Sergio
Publicado: (2020)

DM Authors no. 8
Publicado: (1977)

Molecular biomarkers in diabetes mellitus (DM)
por: Aghaei Zarch, Seyed Mohsen, et al.
Publicado: (2020)

CMB spectral distortions as a probe of DM-$\gamma$ and DM-$\nu$ interactions
por: Diacoumis, James
Publicado: (2018)

The Prevalence and Outcome of pre-DM/DM in an Urban HIV Primary Care Clinic
por: Jeong, Young-Gwang, et al.
Publicado: (2017)

T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
por: Thummasorn, Savitree, et al.
Publicado: (2022)

Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives
por: Mills, Hilla, et al.
Publicado: (2022)

Less Is Better: Single-Digit Brain Functional Connections Predict T2DM and T2DM-Induced Cognitive Impairment
por: Qian, Haotian, et al.
Publicado: (2021)

A Review of Economic Models Submitted to NICE’s Technology Appraisal Programme, for Treatments of T1DM & T2DM
por: Daly, Marie-Josée, et al.
Publicado: (2022)

Cell-free expression, purification, and ligand-binding analysis of Drosophila melanogaster olfactory receptors DmOR67a, DmOR85b and DmORCO
por: Tegler, Lotta Tollstoy, et al.
Publicado: (2015)

I-12 Timothy Syndrome and Cardiomyopathy
por: Bloise, R.
Publicado: (2011)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)

I-20 Wearable monitoring systems and rehabilitation
por: De Rossi, D.
Publicado: (2011)

I-11 News in non dystrophic myotonias
por: Deymeer, F.
Publicado: (2011)

DM Search at the HL-LHC
por: Barranco Navarro, Laura
Publicado: (2019)

Constraining DM properties with SPI
por: Boyarsky, Alexey, et al.
Publicado: (2007)

* Infos DM auteurs no. 7 *
Publicado: (1977)

Retracted: Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

I-23 Respiratory rehabilitation in Duchenne Muscular Dystrophy
por: Fiorentino, G., et al.
Publicado: (2011)

I-5 Emerging treatment strategies in mitochondrial disorders
por: Mancuso, M.
Publicado: (2011)

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

HER2 expression and efficacy of T-DM1
por: Montemurro, Filippo
Publicado: (2014)

SP prevents T2DM complications by immunomodulation
por: Baek, Sang-Min, et al.
Publicado: (2020)

Reversal and Remission of T2DM – An Update for Practitioners
por: Shibib, Lina, et al.
Publicado: (2022)

I-1 History of Myology in Italy and its international collections
por: Angelini, C.
Publicado: (2011)

I-13 Muscle ryanodine receptor in congenital myopathies and channelopathies
por: Treves, S., et al.
Publicado: (2011)

I-18 Chronic muscle electrical stimulation in Myotonic Dystrophy
por: Chisari, C.
Publicado: (2011)

I-10 Pathogenesis of muscle degeneration in periodic paralyses and DMD
por: Lehmann-Horn, F., et al.
Publicado: (2011)

I-15 Neuromyotonia: Potassium channelopathy or non ionic disease?
por: Serratrice, G.
Publicado: (2011)

I-9 Opportunities and challenges of pharmaceutical research and development today
por: Middleton, L.
Publicado: (2011)

I-7 Autoimmune Inflammatory Myopathies: Summary on Pathogenesis and Therapies
por: Dalakas, M.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a51d2bqqvjm4d9tffp6vulqjct